There was no difference in HLH features before treatment in the GPBSC infusion group and the control group (including WBC, HGB, PLT, TG, Fbg, Ferritin, AST, ALT, T-bil) (p > 0.05). This evidence concerns the gene CYGB and hemophagocytic syndrome.